Andrew Combs
Corporate Officer/Principal chez PRELUDE THERAPEUTICS INCORPORATED
Fortune : - $ au 30/04/2024
Postes actifs de Andrew Combs
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Corporate Officer/Principal | 01/04/2019 | - |
Historique de carrière de Andrew Combs
Anciens postes connus de Andrew Combs
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INCYTE CORPORATION | Directeur Financier/CFO | 01/01/2003 | 01/01/2015 |
| Corporate Officer/Principal | 01/01/2015 | 01/02/2019 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2002 | 01/01/2003 |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Corporate Officer/Principal | 01/04/1996 | 01/08/2002 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | 01/04/1996 | 01/08/2002 |
Formation de Andrew Combs
| University of Wisconsin | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| INCYTE CORPORATION | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
- Bourse
- Insiders
- Andrew Combs
- Expérience
